News

August 25, 2015 10:00 am
Selinexor is an orally administered Selective Inhibitor of Nuclear Export, or SINE™, therapy for the treatment of multiple myeloma. Selinexor inhibits the transport of tumor suppressor proteins from the cell nucleus, where they detect cancerous DNA...
August 25, 2015 10:00 am
Emphasizing education, advocacy and support, the IMF Patient & Family Seminars empower patients and provide invaluable information to the myeloma community. Click here to watch the replay.
August 19, 2015 9:45 am
  The IMF Advocacy Team will meet with representatives from the Center for Medicare and Medicaid Services (CMS) next month to discuss current drug- and stem cell transplant-coverage policies. To prepare for the meeting, the IMF has created a short...
August 19, 2015 9:45 am
The IMF is hosting a two-day Patient & Family Seminar August 21-22 at the Sheraton Universal Hotel in Los Angeles, California. Attendees will receive the latest information on myeloma, access to many of the top myeloma experts, and a chance to...

Pages